Latest Organofluorides Stories
DUBLIN, Ireland, August 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ljjdcg/global) has announced the addition of the "Global
ReportsnReports.com adds “2014 Market Research Report on Global and China Trifluoroacetic Acid Industry” market research report to its store. Dallas, TX
The Firm is actively filing Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication.
Multimedia assets associated with the below announcement are now available. Assets include: b-roll footage, corporate sound bites, product images and additional information.
The anti-cancer drug Xalkori® is being investigated by the ECOG-ACRIN Cancer Research Group in E4512, a phase III trial. Philadelphia, PA (PRWEB) August
The Firm is representing numerous clients in Risperdal lawsuits that allege gynecomastia, or male breast development, due to their use of the antipsychotic drug. New
CEO to Present Significance of Announced Clinical Trial Results for Lead Drug G-202 Treating Hepatocellular Carcinoma (HCC) Patients to Wall Street Audience SAN ANTONIO, Aug.
A Rise In Lipitor Lawsuit Claims Jumped In Five Months With Filings That Contend Development Of Type 2 Diabetes After Taking The Cholesterol Lowing Medication, Notes Wright & Schulte LLC
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New
- The act of sweetening by admixture of some saccharine substance.